Concepedia

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Katja Deterding, Christoph D. Spinner, Eckart Schott, Tania M. Welzel, Guido Gerken, Hartwig Klinker, Ulrich Spengler, Johannes Wiegand, Julian Schulze zur Wiesch, Anita Pathil,

The Lancet Infectious Diseases · 2016 · 130 citations · 24 references

DOI

Concepts

References

24

EASL Recommendations on Treatment of Hepatitis C 2018

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations

, , +14

EASL Recommendations on Treatment of Hepatitis C 2015

Journal of Hepatology · 2015 · 1.2K citations

, , +14

Treatment of Acute Hepatitis C with Interferon Alfa-2b

Elmar Jaeckel, Markus Cornberg, Heiner Wedemeyer et al. · New England Journal of Medicine · 2001 · 802 citations · Full text

, , +15

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

Eric Lawitz, Fred Poordad, Phillip S. Pang et al. · The Lancet · 2013 · 549 citations

, , +15

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study

Johannes Wiegand, Peter Buggisch, Wulf O. Boecher et al. · Hepatology · 2006 · 252 citations · Full text

, , +17